Daito Pharmaceutical Co (TSE:4577) Construction In Progress: 円750 Mil (As of Nov. 2025)


TSE:4577 Daito Pharmaceutical Co Ltd TSE:4577
71 GF Score
Price 円1,232.00
GF Value 円1,276.34
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Daito Pharmaceutical Co Construction In Progress?

Daito Pharmaceutical Co TSE:4577 -0.96% 71 Construction In Progress is 円750 Mil as of Nov. 2025. GuruFocus rates TSE:4577 with a GF Score™ of 71/100 and a GF Value™ of 円1,276.34 (Fairly Valued). The stock has 3 warning signs investors should review.

Daito Pharmaceutical Co's quarterly construction in progress declined from May. 2025 (円2,500 Mil) to Aug. 2025 (円1,510 Mil) and declined from Aug. 2025 (円1,510 Mil) to Nov. 2025 (円750 Mil).

Daito Pharmaceutical Co's annual construction in progress declined from May. 2023 (円4,618 Mil) to May. 2024 (円2,194 Mil) but then increased from May. 2024 (円2,194 Mil) to May. 2025 (円2,500 Mil).

Daito Pharmaceutical Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for Daito Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daito Pharmaceutical Co Construction In Progress Chart

Daito Pharmaceutical Co Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,549.00 423.00 4,618.00 2,194.00 2,500.00

Daito Pharmaceutical Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 2,500.00 1,510.00 750.00 899.00
TSE:4577
71GF Score
Daito Pharmaceutical Co Ltd TSE:4577
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daito Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of 円750 Mil mean?
Daito Pharmaceutical Co (TSE:4577) has a Construction In Progress of 円750 Mil as of Nov. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Daito Pharmaceutical Co and its competitors.
Is Daito Pharmaceutical Co's Construction In Progress too high?
Daito Pharmaceutical Co's current Construction In Progress is 円750 Mil. Overall, Daito Pharmaceutical Co has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Daito Pharmaceutical Co's Construction In Progress compare to ZTS and UTHR?
Daito Pharmaceutical Co's Construction In Progress of 円750 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Daito Pharmaceutical Co and its competitors. Daito Pharmaceutical Co's current Construction In Progress is 円750 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daito Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Daito Pharmaceutical Co (TSE:4577) is currently considered Fairly Valued. The stock's GF Value™ is 円1,276.34, compared to a current price of 円1,232.00 — trading 3.5% below its estimated fair value. The current Construction In Progress is 円750 Mil. Daito Pharmaceutical Co's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Daito Pharmaceutical Co (TSE:4577), the current Construction In Progress is 円750 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daito Pharmaceutical Co (TSE:4577) Overvalued in 2026?

Based on GuruFocus' analysis, Daito Pharmaceutical Co stock appears to be undervalued. The current stock price of 円1,232.00 is trading 3.5% below its estimated GF Value™ of 円1,276.34. GuruFocus considers Daito Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TSE:4577:

  • Construction In Progress: 円750 Mil
  • GF Value™: 円1,276.34 vs. price of 円1,232.00 (3.5% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the TSE:4577 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daito Pharmaceutical Co Business Description

Address 326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.
71GF Score

Get the complete analysis for TSE:4577

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,232.00
Price
円1,276.34
GF Value